Integrated network pharmacology, metabolomics, and transcriptomics of Huanglian-Hongqu herb pair in non-alcoholic fatty liver disease
Top Cited Papers
- 5 February 2024
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 325, 117828
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- Science and Technology Department of Sichuan Province
- Chengdu University of Traditional Chinese Medicine
This publication has 32 references indexed in Scilit:
- Effect of homogenization on lipid profiling in Saanen goat milk based on UHPLC-QTOF-MS lipidomicsFood Chemistry, 2023
- System pharmacology analysis to decipher the effect and mechanism of active ingredients combination from herb couple on rheumatoid arthritis in ratsJournal of Ethnopharmacology, 2022
- Breviscapine alleviates NASH by inhibiting TGF‐β‐activated kinase 1‐dependent signalingHepatology, 2021
- Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver diseaseEuropean Journal of Pharmacology, 2021
- Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathwayFree Radical Biology and Medicine, 2019
- Oenological characteristics, amino acids and volatile profiles of Hongqu rice wines during pottery storage: Effects of high hydrostatic pressure processingFood Chemistry, 2016
- G‐protein‐coupled bile acid receptor plays a key role in bile acid metabolism and fasting‐induced hepatic steatosis in miceHepatology, 2016
- MAFG Is a Transcriptional Repressor of Bile Acid Synthesis and MetabolismCell Metabolism, 2015
- Subchronic toxicity study of Coptidis Rhizoma in ratsJournal of Ethnopharmacology, 2014
- Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1Food and Chemical Toxicology, 2013